Describe vaccine production technologies (mRNA, recombinant)

WHY do we even need "new" vaccine technologies?

WHAT is an antigen, exactly?

The central biological fact everything below depends on:

$\text{DNA} \xrightarrow{\text{transcription}} \text{mRNA} \xrightarrow{\text{translation}} \text{protein (antigen)}$

Every vaccine technology just intervenes at a different point of this flow.

1. Recombinant (Subunit) Vaccines

HOW it is made — derive the steps from first principles

The logic: I want protein X. Protein X is encoded by gene X. So put gene X into a fast-growing cell and let the cell's own machinery build protein X for me.

1. Identify & isolate the gene for the antigen (e.g. HBsAg gene of Hepatitis B virus).
   • Why this step? The gene is the blueprint; without it the host cell doesn't know what to build.
2. Insert the gene into a vector (plasmid) using restriction enzymes + DNA ligase → recombinant DNA.
   • Why? A plasmid can self-replicate inside a host and carries the gene in, like a cargo ship.
3. Transform a host (commonly ==yeast Saccharomyces cerevisiae==).
   • Why yeast? It grows fast, is cheap, and can fold + modify eukaryotic proteins correctly.
4. Culture at scale in a fermenter; host transcribes & translates the gene → antigen protein.
5. Purify the antigen (chromatography), add an adjuvant, formulate.
   • Why adjuvant? A lone purified protein is a weak signal; the adjuvant boosts the immune response.

2. mRNA Vaccines

HOW it is made & works — from first principles

The insight: Why manufacture and purify a tricky protein in a factory, when the body is the best protein factory in the world? Just deliver the instructions.

1. Get the antigen's genetic sequence (e.g. spike protein of SARS-CoV-2) — from the pathogen's genome, digitally.
   • Why this is huge: you only need the sequence data, not the physical virus → design possible within days of a genome being published.
2. Synthesise mRNA in vitro using a DNA template + RNA polymerase (no living cells needed).
3. Add key modifications:
   • a 5' cap and poly-A tail → stability + efficient translation.
   • modified nucleosides (e.g. pseudouridine) → reduce innate immune destruction of the mRNA.
   • Why? Naked mRNA is fragile and triggers alarms; modifications let it survive long enough to be translated.
4. Package in lipid nanoparticles (LNPs).
   • Why LNPs? mRNA is large, negatively charged, and can't cross the cell membrane alone. The fatty bubble protects it and fuses with the cell membrane to smuggle it inside.
5. Inject. Cells take up LNPs → ribosomes translate mRNA → antigen made & displayed → immune memory formed.

Comparing the two (the 80/20 core table)

Common Mistakes (Steel-man → Fix)

Forecast-then-Verify

Feynman: explain to a 12-year-old

Mnemonic

Active-Recall Flashcards

Connections

• Recombinant DNA Technology — plasmid vectors, restriction enzymes, ligase (the toolkit for recombinant vaccines)
• Central Dogma of Molecular Biology — DNA → mRNA → protein underpins both methods
• Immune System and Antibodies — how antigens generate memory cells
• Cloning Vectors and Plasmids — how the antigen gene is carried into host cells
• PCR and Gene Amplification — used to obtain/amplify the antigen gene
• Transgenic Organisms — same host-expression logic
• Bioreactors and Downstream Processing — scale-up and purification of recombinant antigen

Concept Map

Hinglish (regional understanding)